Cambridge and London, UK, :Horizon Discovery (Horizon), a leading provider of research tools to support the development of personalized medicines, today announced it has entered into a research collaboration for gene editing at the Institute of Neurology, University College London (UCL). The program of research will focus on the creation of human isogenic disease model […]
AMSBIO is a leading supplier of innovative tools for growing cells in a physiologically relevant manner. A unique Extracellular Matrix (ECM) Mimetic Library for engineering surfaces to direct receptor binding specificity, signalling and growing cells in 3D has been launched. Containing nearly 300 biomimetics of Fibronectin, Vitronectin, Laminin and Collagen, for coating plates or creating […]
Alterations in Wnt expression, surface receptors, signaling partners, and the battery of Wnt-regulated genes (collectively the canonical Wnt pathway) are known to manifest in a variety of clinically relevant disease states, including cancer, osteoporosis, cardiovascular disease, diabetes, and neurodegeneration. Development of Wnt pathway altering drugs requires the ability to rapidly screen the effect of compounds […]
Fremont, California, – DiscoveRx today announced the acquisition of BioSeek, a drug discovery services company based in South San Francisco, California. BioSeek’s phenotypic screening technology improves the success rate of pharmaceutical research and development by integrating primary cell profiling into the drug discovery process. The proprietary BioMAP? systems incorporate primary human cell-based disease models that […]
Franklin Lakes, NJ – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $1.967 billion for the fourth fiscal quarter ended September 30, 2012, representing a decrease of 1.1 percent from the prioryear period, or an increase of 4.7 percent on a foreign currency-neutral basis. For […]
To protect light sensitive samples – Porvair Sciences offers a selection of high quality, black microplates and seals that eliminate sample degradation, even over long storage periods. Manufactured from ultra-pure grade polypropylene, Porvair black microplates are resistant to a wide range of solvents and have near zero leachates ensuring long-term sample integrity. The black plates […]
GSL Biotech announced today that Clontech Laboratories Inc. has selected the company’s flagship software product, SnapGene™, as a solution for cloning simulation and plasmid map drawing. Clontech researchers participated in SnapGene beta testing and provided feedback to SnapGene’s developers on the interface and functionality, including SnapGene’s unique ability to simulate Clontech’s In-Fusion cloning. Andrew Farmer, […]
Franklin Lakes, NJ – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it is pledging up to $500,000, including $250,000 in cash and up to $250,000 in product donations, to support Hurricane Sandy relief efforts. BD’s cash commitment will be shared among the American Red Cross, the United […]
San Francisco, California, and Hilden, Germany, – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the first product launches in its initiative to advance routine workflows in next-generation sequencing (NGS) applications. At the annual meeting of the American Society of Human Genetics (ASHG) in San Francisco, QIAGEN will present four new products that […]
BPS Bioscience, Inc. (“BPS”) announced today the availability of PCSK9 and LDLR proteins, a PCSK9-LDLR Binding Assay Kit, and PCSK9 Screening/Profiling Services for cholesterol-related research. PCSK9 is a critical regulator of cholesterol metabolism through its interaction with the hepatic LDL receptor (LDLR). Circulating PCSK9 binds to the extracellular EGF-like domain of LDLR, followed by endocytosis […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
